Table 1.
Primary Causes | |
Genetic syndromes | Familial hypertriglyceridemia |
Familial combined hyperlipidemia | |
Lipoprotein lipase deficiency | |
Apolipoprotein C-II deficiency | |
Apolipoprotein AV deficiency | |
Dysbetalipoproteinemia | |
Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) deficiency |
|
Secondary Causes | |
Disease | Metabolic syndrome |
Hypothyroidism | |
Diabetes mellitus | |
Central obesity | |
Renal diseases | |
Nephrotic syndrome | |
Autoimmune disorders (e.g. lupus) | |
HIV-associated dyslipidemia | |
Pregnancy (third trimester) | |
Medications | Non-selective beta blockers |
Thiazides | |
Corticosteroids | |
Tamoxifen | |
Raloxifene | |
Oral estrogens | |
Protease inhibitors | |
Retinoic acid | |
Isotretinoin | |
Sirolimus | |
l-asparaginase | |
Bile acid resins | |
Phenothiazines | |
Second-generation antipsychotics | |
Immunosuppressants | |
Diet | Excess alcohol |
Positive-energy balanced diet with saturated fat or high glycemic index/load content |
Republished with permission of Bentham Science Publishers, from Hypertriglyceridemia - common causes, prevention and treatment strategies, Rygiel K, Curr Cardiol Rev 2018[15]; permission conveyed through Copyright Clearance Center, Inc.